- Home
- CRGX vs HIFS Comparison
CRGX vs HIFS Comparison
Compare CRGX & HIFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- HIFS
- Stock Information
- Founded
- CRGX 2021
- HIFS 1834
- Country
- CRGX United States
- HIFS United States
- Employees
- CRGX N/A
- HIFS N/A
- Industry
- CRGX
- HIFS Major Banks
- Sector
- CRGX
- HIFS Finance
- Exchange
- CRGX Nasdaq
- HIFS Nasdaq
- Market Cap
- CRGX 621.4M
- HIFS 518.9M
- IPO Year
- CRGX 2023
- HIFS N/A
- Fundamental
- Price
- CRGX $12.39
- HIFS $241.80
- Analyst Decision
- CRGX Strong Buy
- HIFS
- Analyst Count
- CRGX 6
- HIFS 0
- Target Price
- CRGX $31.80
- HIFS N/A
- AVG Volume (30 Days)
- CRGX 287.3K
- HIFS 12.2K
- Earning Date
- CRGX 11-12-2024
- HIFS 01-17-2025
- Dividend Yield
- CRGX N/A
- HIFS 1.04%
- EPS Growth
- CRGX N/A
- HIFS N/A
- EPS
- CRGX N/A
- HIFS 12.85
- Revenue
- CRGX N/A
- HIFS $65,525,000.00
- Revenue This Year
- CRGX N/A
- HIFS N/A
- Revenue Next Year
- CRGX N/A
- HIFS N/A
- P/E Ratio
- CRGX N/A
- HIFS $18.82
- Revenue Growth
- CRGX N/A
- HIFS N/A
- 52 Week Low
- CRGX $10.91
- HIFS $150.11
- 52 Week High
- CRGX $33.92
- HIFS $300.00
- Technical
- Relative Strength Index (RSI)
- CRGX 39.66
- HIFS 40.81
- Support Level
- CRGX $10.91
- HIFS $235.65
- Resistance Level
- CRGX $15.75
- HIFS $245.96
- Average True Range (ATR)
- CRGX 1.20
- HIFS 5.82
- MACD
- CRGX -0.11
- HIFS -0.43
- Stochastic Oscillator
- CRGX 30.08
- HIFS 47.57
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
About HIFS Hingham Institution for Savings
Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.